|
Market Closed -
NYSE
16:00:03 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 94.66 USD | -0.66% |
|
-2.15% | +19.28% |
| 09-11 | Bernstein Raises CVS Health Price Target to $112 From $106 | MT |
| 09-11 | TPG Explores $5 Billion Sale of Lyric | MT |
| Market Cap | 121B 104B 98.77B 89.52B 168B 11,566B 169B 1,173B 451B 5,884B 455B 445B 18,594B | P/E 2026 * |
13.8x | P/E 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 173B 149B 141B 128B 240B 16,525B 241B 1,676B 645B 8,407B 650B 635B 26,566B | EV / Sales 2026 * |
0.41x | EV / Sales 2027 * | 0.4x |
| Free-Float |
71.17% | Yield 2026 * |
2.81% | Yield 2027 * | 2.89% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CVS | Delayed | |
CBOE
| CVS | Real-time | |
|
Tradegate
| CVS | Real-time | |
|
London S.E.
| 0HRS | Delayed | |
|
Mexican S.E.
| CVS * | End-of-day quote | |
|
Xetra
| CVS | Delayed | |
|
Boerse Muenchen
| CVS | Real-time | |
|
Borsa Italiana
| 1CVS | End-of-day quote | |
|
Deutsche Boerse AG
| CVS | Delayed | |
|
Swiss Exchange
| CVS | Delayed | |
|
CBOE
| Real-time | ||
|
CBOE
| 0HRS | Real-time | |
|
Santiago S.E.
| CVS | End-of-day quote | |
|
Santiago S.E.
| CVSCL | End-of-day quote | |
|
Lima
| CVSUS | End-of-day quote | |
|
Wiener Boerse
| CVS | End-of-day quote | |
|
Börse Stuttgart
| CVS | Delayed | |
|
Swiss Exchange
| CVS | Delayed |
Last Transcript : CVS Health Corporation
| 1 day | -0.66% | ||
| 1 week | -2.15% | ||
| Current month | +0.80% | ||
| 1 month | +1.24% | ||
| 3 months | -5.79% | ||
| 6 months | +25.01% | ||
| Current year | +19.28% |
| 1 week | 92.79 |  | 97.98 |
| 1 month | 92.35 | | 98.5 |
| Current year | 69.51 | | 110.68 |
| 1 year | 69.51 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/31/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 5/31/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% | ||
| 5/21/26 | Glenview Capital Management LLC
| Sell | Company | -748,462 | 0.0584% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.66% | -2.15% | +26.77% | +37.69% | 121B | |
| +1.36% | +5.42% | +5.98% | +56.69% | 92.43B | |
| +0.75% | +3.23% | -4.37% | +57.98% | 29.44B | |
| +1.68% | -0.89% | +28.10% | +85.48% | 25.94B | |
| -0.13% | +1.09% | +0.13% | -2.23% | 21.69B | |
| +0.09% | -0.51% | +36.36% | +259.30% | 21.23B | |
| -1.18% | +1.29% | -4.52% | +28.01% | 16.07B | |
| -0.13% | -1.99% | -10.17% | -3.17% | 11.82B | |
| +0.12% | -1.33% | +36.26% | +88.60% | 11.58B | |
| -0.17% | +5.30% | -12.02% | +67.09% | 10.57B | |
| Average | +0.17% | +1.03% | +10.25% | +67.54% | 36.18B | |
| Weighted average by Cap. | +0.25% | +1.07% | +14.56% | +58.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 418B 360B 341B 309B 579B 39,901B 582B 4,047B 1,556B 20,300B 1,569B 1,534B 64,146B | 430B 370B 350B 318B 596B 41,035B 599B 4,162B 1,600B 20,877B 1,613B 1,578B 65,968B |
| Net income | 8.88B 7.65B 7.24B 6.56B 12.31B 848B 12.38B 86B 33.07B 431B 33.33B 32.6B 1,363B | 9.32B 8.03B 7.6B 6.89B 12.93B 890B 12.99B 90.3B 34.72B 453B 35B 34.23B 1,431B |
| Net Debt | 51.91B 44.72B 42.35B 38.38B 72.01B 4,959B 72.37B 503B 193B 2,523B 195B 191B 7,972B | 48.85B 42.09B 39.86B 36.13B 67.77B 4,667B 68.12B 473B 182B 2,375B 183B 179B 7,503B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | US$94.66 | -0.66% | 4,380,268 |
| 26-09-10 | US$95.29 | -0.09% | 3,877,979 |
| 26-09-09 | US$95.38 | -0.72% | 6,112,458 |
| 26-09-08 | US$96.07 | -0.69% | 4,196,553 |
| 26-09-04 | US$96.74 | -0.47% | 4,499,060 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
